ArticleFrontiers in endocrinology2025
Primary adrenal lymphoma and its mimics: clinico-radiological differential diagnosis.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adrenal lymphoma with hypertension: A report of three cases.Oncology letters · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Primary adrenal lymphoma (PAL) is a rare malignancy with limited data on its characteristics. It can pose diagnostic challenges in differentiating it from other adrenal masses, such as atypical adrenal adenoma (ADE), pheochromocytoma (PCC), and adrenocortical carcinoma (ACC). This study aimed to characterize patients with PAL and compare their clinical, hormonal, and radiological features with other primary adrenal lesions whose computed tomography characteristics do not match those of a typical adenoma. Methods: This retrospective, single-center study included four patient cohorts: PAL (n=12), ADE (n=31), PCC (n=18), and ACC (n=19), treated at a tertiary care hospital between January 2013 and January 2024. Results: The histopathological type of all PAL cases was diffuse large B-cell lymphoma (DLBCL). The median age at diagnosis was 70.5 (51-76) years. The diagnosis was more prevalent in males (sex ratio 1.4). Bilateral adrenal involvement was significantly more frequent in PAL patients. Clinical symptoms included general health deterioration (100%), weight loss (75%), abdominal pain (58%) and fever (41.7%). Laboratory assessments showed a higher prevalence of anemia in PAL patients compared to ADE and PCC patients. PAL cases exhibited elevated lactate dehydrogenase (LDH) and β2-microglobulin as well as lipid profile abnormalities. Radiologically, PAL lesions were predominantly homogeneous, with a median tumor size of 78.5 (20-100.5) mm. All lesions exhibited an attenuation value > 20 Hounsfield Unit (HU) and lacked calcifications. Malignant lymph node involvement was significantly more frequent in the PAL than other cohorts. Conclusion: PAL should be included in the differential diagnosis of adrenal masses, particularly in cases of bilateral involvement. This study offers insights into its clinical presentation and highlights distinguishing features compared to other primary adrenal malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.